Abstract
This presentation is based on the idea that genomic alterations by carcinogens are crucial to the production of tumors. The objective is to provide insight as to how investigators may wish to approach the identification and characterization of metabolic activation pathways, as well as the clarification of the role of these pathways in the induction of tumors. It is not intended to be an encyclopedic review, but rather a communication that reflects personal experience in the field of aromatic amines and the external influences of the carcinogenesis community. Hopefully, it will serve both as an introduction to the subsequent chapters of this book and as a framework for the investigation of the mechanisms by which other as yet unstudied compounds cause cancer.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Doll R, Peto R: The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst (66): 1191–1308, 1981.
Parkes HG: The epidemiology of aromatic amine cancers. In: CE Searle (ed) Chemical Carcinogens, Monograph No. 173. American Chemical Society, Washington, DC, 1976, pp 462–480.
King CM, Wang CY, Lee M-S, Vaught JB, Hirose M, Morton KC: Metabolic activation of aromatic amines and the induction of liver, mammary gland and urinary bladder tumors in the rat. In: Rydstrom J, Montelius J, Bengtsson M (ed) Extrahepatic Drug Metabolism and Chemical Carcinogenesis. Elsevier Science Publishers, Amsterdam, 1983, pp 557–566.
Gilden RV, Rice NR: Oncogenes. Carcinogenesis (4): 791–794, 1983.
Sesnowitz-Horn S, Adelberg A: Proflavin treatment of E. Coli generation of frameshift mutants. Cold Spring Harbor Symp Quant Biol (33): 393–402, 1968.
Dipple A: Polynuclear aromatic carcinogens. In: Searle CE (ed) Chemical Carcinogens, Monograph No. 173. American Chemical Society, Washington, DC, 1976, pp 245–314.
Environmental Health Perspectives (49): 1–243, 1983.
Jerina DM, Lehr R, Schaefer-Ridder M, Yagi H, Karle JM, Thakker DR, Wood AW, Lu AYH, Ryan D, West S, Levin W, Conney AH: Bay-region epoxides of dihydrodiols: A concept explaining the mutagenic and carcinogenic activity of benzo[a]pyrene and benzo[a]anthracene. In: Hiatt HH, Watson JD, Winsten JA (eds) Origins of human cancer. Book B. Mechanisms of Carcinogenesis, Cold Spring Harbor Cenferences on Cell Proliferation, Volume 4, Cold Spring Harbor Laboratory, 1977, pp 639–658.
Gulino PM, Pettigrew HM, Grantham FH: N-Nitrosomethlyurea as mammary carcinogen in rats. J Natl Cancer Inst (54): 401–414, 1975.
Hicks RM, Wakefield JSTJ: Rapid induction of bladder cancer in rats with N-Methyl-N-nitrosourea, I. Histology. Chem-Biol Interactions (5): 139–152, 1972.
Nelson N: The chioro ethers: occupational carcinogens, A summary of laboratory and epidemiology studies. Ann NY Acad Sci (271): 81, 1976.
Miller EC: Some current perspectives on chemical carcinogenesis in humans and experimental animals: presidential address. Cancer Res (38), 1479–1496, 1978.
Miller EC, Miller JA, Hartman HA: N-hydroxy-2-acetylaminofluorene, a metabolite of 2-acetylaminofluorene with increased carcinogenic activity in the rat. Cancer Res (31): 815–824, 1961.
King CM, Phillips B: Enzyme-catalyzed reactions of the carcinogen N-hydroxy-2-fluorenylacetamide with nucleic acid, Science (Wash) (159): 1351–1353, 1968.
Miller EC, Miller JA: The presence and significance of bound aminoazo dyes in the livers of rats fed E-dimethylaminoazobenzene. Cancer Res (7): 468–480, 1947.
Baird WM: The use of radioactive Carcinogens to detect DNA modifications. In: Grover PL (ed) Chemical Carcinogens and DNA, Vol. 2. Boca Raton, Florida, CRC Press, 1979, pp 59–83.
King CM, Phillips B: N-Hydroxy-2-fluorenylacetamide: reaction of the carcinogen with guanosine, ribonucleic acid, deoxyribonucleic acid, and protein following enzymatic deacetylation or esterification. J Biol Chem (224): 2609–2616, 1969.
Poirier MC, True BA, Laishes BA: Determination of 2-acetylaminofluorene adducts by immunoassay. Environmental Health Perspectives (49): 93–99, 1982.
King CM, Kriek E: The differential reactivity of the oxidation products of o-aminophenols towards protein and nucleic acid. Biochim-Biophys Acta (111): 147–153, 1965.
King CM, Phillips B: The non-reactivity of 1,2-fluorenoquinone-2-acetamide with DNA and sRNA. Biochem Pharmacol (17): 833–835, 1968.
DeBaun JR, Miller EC, Miller JA: N-Hydroxy-2-acetylaminofluorene sulfotransferase: its probable role in carcinogenesis and protein-(methion-S-yl) binding in rat liver. Cancer Res (30): 577–595, 1970.
Bartsch H, Dworkin M, Miller J A, Miller EC: Electrophilic N-acetoxyaminoarenes derived from carcinogenic N-hydroxy-N-acetylaminoarenes by enzymatic deacetylation arid transacetylation in liver. Biochim Biophys Acta (286): 272–298, 1972.
Westra JG, Kriek E, Hittenhausen H: Identification of the persistently bound form of the carcinogen N-acetyl-2-aminofluorene to rat liver DNA in vivo. Chem-Biol Interactions (15): 287–303, 1976.
King CM: Mechanism of reaction, tissue distribution and inhibition of arylhydroxamic aid acyltransferase. Cancer Res (34): 1503–1516, 1974.
Lee M-S, King CM: New synthesis of N-(guanosin-8-yl)-4-aminobiphenyl and its 5’monophosphâte. Chem-Biol Interactions (34): 239–248, 1981.
King CM, Traub NR, Cardona RA, Howard RB: Comparative adduct formation of 4-aminobiphenyl and 2-aminofluorene derivatives with macromolecules of isolated liver parenchymal cells. Cancer Res (36): 2374–2381, 1976.
McQueen CA, Maslansky CJ, Williams GM: Role of the acetylation polymorphism in determining susceptibility of cultured rabbit hepatocytes to DNA damage by aromatic amines. Cancer Res (43): 3120–3123, 1983.
Howard PC, Casciano DA, Beland FA, Shaddock JG Jr: The binding of N-hydroxy-2-acetylaminofluorene to DNA and repair of the adducts in primary rat hepatocyte culture. Carcinogenesis (2): 97–102, 1981.
Staino N, Erickson LC, Smith CL, Marsden E, Thorgeirsson S: Mutagenicity and DNA damage induced by arylamines in the Salmonella/hepatocyte system. Carcinogenesis (4): 161–167, 1983.
Shirai T, King CM: Sulfotransferase and deacetylase in normal and tumor-bearing liver of CD rats: autoradiographic studies with N-hydroxy-2-acetylaminofluorene and N-hydroxy-4-acetylaminobiphenyl in vitro and in vivo. Carcinogenesis (3): 1385–1391, 1982.
Wang CY, Linsmaier-Bednar EM, Garner CD, Lee M-S: Induction of unscheduled DNA synthesis in primary culture of dog, rat and mouse urothelial cells by arylamine and nitrofuran derivatives. Cancer Res (42): 3974–3977, 1982.
Wang CY, Garner CD, Lee M-S, Shirai T: 0-esters of N-acylhydroxylamines: toxicity and enhancement of sister-chromatid exchange in Chinese hamster ovary cells. Mutation Res (88): 81–88, 1981.
Parke DV: The biochemistry of foreign compounds. Pergamon Press, New York, 1968, pp 34–98.
Glowinski IB, Savage L, Lee M-S, King CM: Relationship between nucleic acid adduct formation and deacylation of arylhydroxamic acids. Carcinogenesis (4): 67–75, 1983.
Irving CC, Russell LT: Synthesis of the o-glucuronide of N-2-fluorenylhydroxylamine: reaction with nucleic acids and with guanosine-5’-monophosphate. Biochemistry (9): 2471–2476, 1970.
Morton KC, King CM, Vaught JB, Wang CY, Lee M-S, Marnett LJ: Prostaglandin H synthase-catalyzed reaction of carcinogenic arylamines with tRNA and homopolyribonucleotides. Biochem Biophys Res Commun (111): 96–103, 1983.
Kriek E, Reitsema J: Interaction of the carcinogen N-acetoxy-2-acetylaminofluorene with polyadenylic acid: dependence of reactivity on conformation. Chem-Biol Interactions (3): 397–400, 1971.
Moore PD, Koreeda M: Application of the change in partition coefficients with pH to the structure determination of alkyl-substituted guanosines. Biochem Biophys Res Commun (73): 459–464, 1976.
Grover PL (ed) Chemical Carcinogens and DNA, Volumes I and II, CRC Press, Boca Raton, Florida, 1979, pp 440.
Phillips DH, Sims P: Polycyclic aromatic hydrocarbon metabolites: Their reactions with nucleic acids. In: Grover PL (ed) Chemical Carcinogens and DNA, Volume II, CRC Press, Boca Raton, Florida, 1979, 29–58.
Rannug U, Sundvall A, Ramel C: The mutagenic effect of 1,2-dichloroethane on Salmonella typhimuriumI. activation through conjugation with glutathione in vitro.Chem-Biol Interactions (20): 1–16, 1978.
Glowinski IB, Fysh JM, Vaught JB, Weber WW, King CM: Evidence for common genetic control of arylhydroxamic acid N-O-acyltransferase and N-acetyltransferase of rabbit liver. J Biol Chem (255): 7883–7890, 1980.
Lotlikar PD, Zaleski K: Ring-and N-hydroxylation of 2-acetylaminofluorene by rat liver reconstituted cytochrome P-450 enzyme system. Biochem J (150): 561–564, 1975.
Slaga TJ, Gleason GL, Mills G, Wald LE, Fu PP, Lee HM, Harvey RG: Comparison of the skin tumor-initiating activities of dihydrodiols and diol-epoxides of various polycyclic aromatic hydrocarbons. Cancer Res (40): 1981–1984, 1980.
Allaben WT, Weeks CE, Weis CC, Burger GT, King CM: Rat mammary gland carcinogenesis after local injection of N-hydroxy-N-acyl-2-aminofluorenes: relationship to metabolic activation. Carcinogenesis (3): 233–240, 1982.
King CM, Allaben, WT: Arylhydroxamic acid acyltransferase. In: Jakoby WB (ed) Enzymatic Basis of Detoxication. Academic Press, New York, 1980, pp 187–197.
Gaugler BJM, Neumann H-G: The binding of metabolites formed from aminostilbene derivatives to nucleic acids in the liver of rats. Chem-Biol Interactions (24): 355–372, 1979.
Clayson DB, Garner RC: Carcinogenic aromatic amines and related compounds. In: Searle CE (ed) Chemical Carcinogens, Monograph No. 173, American Chemical Society, Washington DC, 1976, pp 366–461.
Shirai T, Lee M-S, Wang CY, King, CM: Effects of partial hepatectomy and dietary phenobarbital on liver and mammary tumorigenesis by two N-hydroxy-N-acylaminobiphenyls in female CD rats. Cancer Res (41): 2450–2456, 1981.
Hilbert D, Romen W, Neumann H-G: The role of partial hepatectomy and promoters in the formation of tumors in non-target tissues of trans-4-acetylaminostilbene in rats. Carcinogenesis (4): 1519–1525, 1983.
Mulder GJ, Meerman JHN: Sulfation and glucuronidation as competing pathways in the metabolism of hydroxamic acids: The role of N,O-sulfonation in chemical carcinogenesis of aromatic amines. Environmental Health Perspectives (49): 27–32, 1983.
Dao TL: Studies on mechanism of carcinogenesis in the mammary gland. Progr Exptl Tumor Res (11): 235–261, 1969.
Malejka-Giganti D, Rydell RE, Gutmann HR: Mammary carcinogenesis in the rat by topical application of fluorenylhydroxamic acids and their acetates. Cancer Res (37): 111–117, 1977.
Irving CC: Species and tissue variations in the metabolic activation of aromatic amines. In: Griffin AC, Shaw CR (eds) Carcinogens: Identification and Mechanisms of Action, Raven Press, New York, 1979, pp 211–228.
Irving CC, Janss DH, Rusell LT: Lack of N-hydroxy-2-acetylaminofluorene sulfotransferase activity in the mammary gland and Zymbal’s gland of the rat. Cancer Res (31): 387–391, 1977.
Wirth PJ, Thorgeirsson SS: Mechanism of N-hydroxy-2-acetylaminofluorene mutagenicity in the Salmonellatest system. Role of N,O-acyltransferase and sulfotransferase from rat liver. Mol Pharmacol (19): 337–344, 1981.
Weeks CE, Allaben WT, Louie SC, Lazear EJ, King CM: Role of hydroxamic acid acyltransferase in the mutagenicity of N-hydroxy-N-2-fluorenylacetamine in Salmonella typhimurium Cancer Res (38): 613–618, 1978.
Shirai T, Fysh JM, Lee M-S, Vaught JB, King CM: N-Hydroxy-N-acylarylamines: relationship of metabolic activation to biological response in the liver and mammary gland of the female CD rat. Cancer Res (41): 4346–4353, 1981.
King CM, Traub NR, Lortz ZM, Thissen MR: Metabolic activation of arylhydroxamic acid N-O-acyltransferase of rat mammary gland, Cancer Res (39): 3369–3372, 1979.
Allaben WT, Weis CC, Fullerton NF, Beland, FA: Formation and persistance of DNA adducts from the carcinogen N-hydroxy-2-acetylaminofluorene in rat mammary gland in vivo. Carcinogenesis (4): 1067–1070, 1983.
Irving CC, Wiseman R, Hill JT: Bilary excretion of the o-glucuronide of N-hydroxy-2-acetylaminofluorene by the rat and rabbit. Cancer Res (27): 2309–2317, 1967.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Martinus Nijhoff Publishing, Boston
About this chapter
Cite this chapter
King, C.M. (1985). Metabolism and the “Initiation” of Tumors by Chemicals. In: Marnett, L.J. (eds) Arachidonic Acid Metabolism and Tumor Initiation. Prostaglandins, Leukotrienes, and Cancer, vol 2. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2611-3_1
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2611-3_1
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9634-8
Online ISBN: 978-1-4613-2611-3
eBook Packages: Springer Book Archive